ENTO ENTERO THERAPEUTICS INC Company Mergers 8-K Filing 2025 - Merger Rescission Entero Therapeutics, Inc. announced on March 24, 2025, that it has entered into a Rescission Agreement to unwind a previous merger with ImmunogenX, Inc. that occurred on March 13, 2024, involving the return of shares and cancellation of options and warrants.Get access to all SEC 8-K filings of the ENTERO THERAPEUTICS INC